| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Tuberculosis | D014376 | 20 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Leukemia P388 | D007941 | 43 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
816-94-4
816-94-4 is a lipid of Glycerophospholipids (GP) class. 816-94-4 is associated with abnormalities such as Gigantism, Pulmonary Hypertension, Neutropenia, Serum Sickness and Urticaria. The involved functions are known as pulmonary effects, Hemodynamics, Stereochemistry, Host defense and Blood Circulation. 816-94-4 often locates in vesicle, Blood, biological membrane, soluble and Cardiopulmonary. The associated genes with 816-94-4 are pentaglobulin, EMILIN1 gene and FASTK Gene. The related lipids are Liposomes, dimyristoylphosphatidylglycerol, Lipopolysaccharides, Unilamellar Liposomes and Unilamellar Vesicles.
Cross Reference
Introduction
To understand associated biological information of 816-94-4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 816-94-4?
816-94-4 is suspected in Pulmonary Hypertension, Cholera, Gigantism, Neutropenia, Serum Sickness, Urticaria and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 816-94-4
PubChem Associated disorders and diseases
What pathways are associated with 816-94-4
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 816-94-4?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 816-94-4?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 816-94-4?
Related references are published most in these journals:
- Essays Biochem. (1)
- J. Pharmacol. Exp. Ther. (1)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- Others (1)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 816-94-4?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 816-94-4?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 816-94-4
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Huang A et al. | N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin. | 2011 | Drug Deliv | pmid:21823926 |
| Tsotas VA et al. | Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability. | 2007 | Drug Deliv | pmid:17994361 |
| Briuglia ML et al. | Influence of cholesterol on liposome stability and on in vitro drug release. | 2015 | Drug Deliv Transl Res | pmid:25787731 |
| Wehbe M et al. | Development of a copper-clioquinol formulation suitable for intravenous use. | 2018 | Drug Deliv Transl Res | pmid:29247315 |
| Al Asmari AK et al. | Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. | 2016 | Drug Des Devel Ther | pmid:26834457 |
| Alvarez-Figueroa MJ et al. | Use of DMPC and DSPC lipids for verapamil and naproxen permeability studies by PAMPA. | 2015 | Drug Dev Ind Pharm | pmid:24568608 |
| Ackerman DG and Feigenson GW | Lipid bilayers: clusters, domains and phases. | 2015 | Essays Biochem. | pmid:25658342 |
| Ogihara-Umeda I and Kojima S | Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors. | 1989 | Eur J Nucl Med | pmid:2598958 |
| Murata M et al. | Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration. | 2014 | Eur J Pharm Biopharm | pmid:24055689 |
| Ingvarsson PT et al. | The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models. | 2014 | Eur J Pharm Biopharm | pmid:24726978 |
| Magarkar A et al. | A computational study suggests that replacing PEG with PMOZ may increase exposure of hydrophobic targeting moiety. | 2017 | Eur J Pharm Sci | pmid:28285174 |
| Pavelić Z et al. | Liposomes containing drugs for treatment of vaginal infections. | 1999 | Eur J Pharm Sci | pmid:10425385 |
| Kirjavainen M et al. | Influence of lipids on the mannitol flux during transdermal iontophoresis in vitro. | 2000 | Eur J Pharm Sci | pmid:10727874 |
| Song C et al. | Articaine interaction with DSPC bilayer: a 13C and 31P solid-state NMR study. | 2008 | Eur J Pharm Sci | pmid:18343644 |
| Han HK et al. | Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. | 2012 | Eur J Pharm Sci | pmid:22522117 |
| Konovalov O et al. | Lipid discrimination in phospholipid monolayers by the antimicrobial frog skin peptide PGLa. A synchrotron X-ray grazing incidence and reflectivity study. | 2002 | Eur. Biophys. J. | pmid:12355252 |
| Balvers WG et al. | Kinetics of cytochromes P-450 IA1 and IIB1 in reconstituted systems with dilauroyl- and distearoyl-glycerophosphocholine. | 1993 | Eur. J. Biochem. | pmid:8344304 |
| Lange LG et al. | Hemolysis of rat erythrocytes by replacement of the natural phosphatidylcholine by various phosphatidylcholines. | 1980 | Eur. J. Biochem. | pmid:6893690 |
| Rietjens IM et al. | On the role of phospholipids in the reconstituted cytochrome P-450 system. A model study using dilauroyl and distearoyl glycerophosphocholine. | 1989 | Eur. J. Biochem. | pmid:2496984 |
| Deleers M et al. | Inhibition by calcium antagonists of ionophore-mediated calcium transport in liposomes. | 1982 | Eur. J. Pharmacol. | pmid:6897041 |
| Liu J et al. | The effect of cholesterol on the intrinsic rate of lipid flip-flop as measured by sum-frequency vibrational spectroscopy. | 2013 | Faraday Discuss. | pmid:23805737 |
| Santaella C et al. | Extended in vivo blood circulation time of fluorinated liposomes. | 1993 | FEBS Lett. | pmid:8282115 |
| Maruyama K et al. | Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. | 1997 | FEBS Lett. | pmid:9287139 |
| Nakamura W | [Strategy for thermochemotherapy of cancer]. | 1983 | Gan To Kagaku Ryoho | pmid:6347077 |
| Dohmitsu K et al. | [Hyper-thermo chemotherapy of esophageal cancer with thermosensitive liposome, TAC-1043]. | 1991 | Gan To Kagaku Ryoho | pmid:1877816 |
| Hsiao SM et al. | Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum. | 2009 | Gynecol. Oncol. | pmid:18977021 |
| Bhowmick S et al. | gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani. | 2008 | Infect. Immun. | pmid:18195029 |
| Howard FB and Levin IW | Lipid vesicle aggregation induced by cooling. | 2010 | Int J Mol Sci | pmid:20386666 |
| Abbasi S et al. | Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion. | 2016 | Int J Nanomedicine | pmid:27354798 |
| Wehbe M et al. | Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent. | 2017 | Int J Nanomedicine | pmid:28615941 |
| Accardo A et al. | Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. | 2012 | Int J Nanomedicine | pmid:22619538 |
| Xu X et al. | Predicting hydrophilic drug encapsulation inside unilamellar liposomes. | 2012 | Int J Pharm | pmid:22207162 |
| Banerjee S et al. | Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy. | 2012 | Int J Pharm | pmid:22884831 |
| Guimarães Sá Correia M et al. | Microfluidic manufacturing of phospholipid nanoparticles: Stability, encapsulation efficacy, and drug release. | 2017 | Int J Pharm | pmid:27840162 |
| Papadia K et al. | How do the physicochemical properties of nanoliposomes affect their interactions with the hCMEC/D3 cellular model of the BBB? | 2016 | Int J Pharm | pmid:27286634 |
| Guse C et al. | Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids. | 2006 | Int J Pharm | pmid:16517106 |
| Pedersen TB et al. | A calorimetric study of phosphocholine membranes mixed with desmopressin and its diacylated prodrug derivative (DPP). | 2002 | Int J Pharm | pmid:11897424 |
| Awasthi VD et al. | Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. | 2003 | Int J Pharm | pmid:12593943 |
| Bhardwaj U and Burgess DJ | Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. | 2010 | Int J Pharm | pmid:20079409 |
| Bhardwaj U and Burgess DJ | A novel USP apparatus 4 based release testing method for dispersed systems. | 2010 | Int J Pharm | pmid:20083176 |
| Hussain MD et al. | Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance. | 2012 | Int J Pharm | pmid:22101290 |
| Zagana P et al. | In vivo distribution of arsonoliposomes: effect of vesicle lipid composition. | 2008 | Int J Pharm | pmid:17689900 |
| Ricci M et al. | Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation. | 2006 | Int J Pharm | pmid:16439072 |
| Hatzi P et al. | Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition. | 2007 | Int J Pharm | pmid:17101248 |
| Ichikawa K et al. | Enhanced desensitization efficacy by liposomal conjugation of a specific antigen. | 2007 | Int J Pharm | pmid:17234372 |
| Chaudhury A et al. | Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration. | 2012 | Int J Pharm | pmid:22537806 |
| Zalutsky MR et al. | Use of liposomes as carriers for radiation synovectomy. | 1988 | Int J Rad Appl Instrum B | pmid:2835332 |
| Zalutsky MR et al. | Properties of multilamellar liposomes containing 99mTcO4-: effect of distearoylphosphatidylcholine to sphingomyelin ratio. | 1986 | Int J Rad Appl Instrum B | pmid:3021689 |
| Ogihara-Umeda I et al. | Development of a liposome-encapsulated radionuclide with preferential tumor accumulation--the choice of radionuclide and chelating ligand. | 1992 | Int J Rad Appl Instrum B | pmid:1399696 |
| Siddikuzzaman VM and Grace | Inhibition of metastatic lung cancer in C57BL/6 mice by liposome encapsulated all trans retinoic acid (ATRA). | 2012 | Int. Immunopharmacol. | pmid:23021983 |